Sperabillin A

Drug Profile

Sperabillin A

Alternative Names: TAN 749

Latest Information Update: 13 Oct 2000

Price : $50

At a glance

  • Originator Takeda
  • Class Antibacterials; Antineoplastics
  • Mechanism of Action Cell wall inhibitors; DNA synthesis inhibitors; Protein synthesis inhibitors; RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 13 Oct 2000 Discontinued-Unspecified phase in Bacterial infections in Japan (Unknown route)
  • 12 Jun 2000 Profile reviewed but no significant changes made
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top